| Year |
Citation |
Score |
| 2024 |
Vaccarino SR, Wang S, Rizvi SJ, Lou W, Hassel S, MacQueen GM, Ho K, Frey BN, Lam RW, Milev RV, Rotzinger S, Ravindran AV, Strother SC, Kennedy SH. Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder. Bjpsych Open. 10: e18. PMID 38179598 DOI: 10.1192/bjo.2023.588 |
0.353 |
|
| 2023 |
Mazurka R, Cunningham S, Hassel S, Foster JA, Nogovitsyn N, Fiori LM, Strother SC, Arnott SR, Frey BN, Lam RW, MacQueen GM, Milev RV, Rotzinger S, Turecki G, Kennedy SH, et al. Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 78: 71-80. PMID 38128154 DOI: 10.1016/j.euroneuro.2023.12.003 |
0.335 |
|
| 2023 |
Rnic K, LeMoult J, Torres IJ, Chakrabarty T, Foster J, Frey BN, Harkness KL, Ho K, Li QS, Milev R, Quilty LC, Rotzinger S, Soares CN, Uher R, Kennedy SH, et al. Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) report. Psychiatry Research. 330: 115606. PMID 37979318 DOI: 10.1016/j.psychres.2023.115606 |
0.393 |
|
| 2023 |
Phaterpekar T, Nunez JJ, Morton E, Liu YS, Cao B, Frey BN, Milev RV, Müller DJ, Rotzinger S, Soares CN, Taylor VH, Uher R, Kennedy SH, Lam RW. Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 85. PMID 37967350 DOI: 10.4088/JCP.23m14864 |
0.33 |
|
| 2023 |
Nunez JJ, Liu YS, Cao B, Frey BN, Ho K, Milev R, Müller DJ, Rotzinger S, Soares CN, Taylor VH, Uher R, Kennedy SH, Lam RW. Response trajectories during escitalopram treatment of patients with major depressive disorder. Psychiatry Research. 327: 115361. PMID 37523890 DOI: 10.1016/j.psychres.2023.115361 |
0.332 |
|
| 2023 |
Schwartzmann B, Quilty LC, Dhami P, Uher R, Allen TA, Kloiber S, Lam RW, Frey BN, Milev R, Müller DJ, Soares CN, Foster JA, Rotzinger S, Kennedy SH, Farzan F. Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study. Scientific Reports. 13: 8418. PMID 37225718 DOI: 10.1038/s41598-023-35179-4 |
0.349 |
|
| 2023 |
Husain MI, Foster JA, Mason BL, Chen S, Zhao H, Wang W, Rotzinger S, Rizvi S, Ho K, Lam R, MacQueen G, Milev R, Frey BN, Müller D, Turecki G, et al. Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report. Cns Spectrums. 1-28. PMID 37218291 DOI: 10.1017/S109285292300233X |
0.338 |
|
| 2023 |
Fu CHY, Erus G, Fan Y, Antoniades M, Arnone D, Arnott SR, Chen T, Choi KS, Fatt CC, Frey BN, Frokjaer VG, Ganz M, Garcia J, Godlewska BR, Hassel S, ... ... Rotzinger S, et al. AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale. Bmc Psychiatry. 23: 59. PMID 36690972 DOI: 10.1186/s12888-022-04509-7 |
0.311 |
|
| 2022 |
Sajjadian M, Uher R, Ho K, Hassel S, Milev R, Frey BN, Farzan F, Blier P, Foster JA, Parikh SV, Müller DJ, Rotzinger S, Soares CN, Turecki G, Taylor VH, et al. Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report. Psychological Medicine. 1-11. PMID 36004538 DOI: 10.1017/S0033291722002124 |
0.373 |
|
| 2022 |
Harris JK, Hassel S, Davis AD, Zamyadi M, Arnott SR, Milev R, Lam RW, Frey BN, Hall GB, Müller DJ, Rotzinger S, Kennedy SH, Strother SC, MacQueen GM, Greiner R. Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report. Neuroimage. Clinical. 35: 103120. PMID 35908308 DOI: 10.1016/j.nicl.2022.103120 |
0.31 |
|
| 2022 |
Hicks O, McInerney SJ, Lam RW, Milev RV, Frey BN, Soares CN, Foster JA, Rotzinger S, Kennedy SH, Harkness KL. Acute and chronic stress predict anti-depressant treatment outcome and naturalistic course of major depression: A CAN-BIND report. Journal of Affective Disorders. PMID 35760190 DOI: 10.1016/j.jad.2022.06.058 |
0.301 |
|
| 2022 |
Mosabbir AA, Braun Janzen T, Al Shirawi M, Rotzinger S, Kennedy SH, Farzan F, Meltzer J, Bartel L. Investigating the Effects of Auditory and Vibrotactile Rhythmic Sensory Stimulation on Depression: An EEG Pilot Study. Cureus. 14: e22557. PMID 35371676 DOI: 10.7759/cureus.22557 |
0.349 |
|
| 2022 |
Espinola CW, Khoo Y, Parmar R, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy. Brain and Behavior. e2555. PMID 35333448 DOI: 10.1002/brb3.2555 |
0.346 |
|
| 2022 |
Dhami P, Quilty LC, Schwartzmann B, Uher R, Allen TA, Kloiber S, Lam RW, MacQueen G, Frey BN, Milev R, Müller DJ, Strother SC, Blier P, Soares CN, Parikh SV, ... ... Rotzinger S, et al. Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A CAN-BIND Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 35032682 DOI: 10.1016/j.bpsc.2021.12.012 |
0.325 |
|
| 2021 |
Khoo Y, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Baseline Anxiety, and Early Anxiety/Depression Improvement in Anxious Depression Predicts Treatment Outcomes with Escitalopram: A CAN-BIND-1 Study Report. Journal of Affective Disorders. PMID 34921820 DOI: 10.1016/j.jad.2021.12.027 |
0.378 |
|
| 2021 |
Fiori LM, Orri M, Aouabed Z, Théroux JF, Lin R, Nagy C, Frey BN, Lam RW, MacQueen GM, Milev R, Müller DJ, Parikh SV, Rotzinger S, Uher R, Foster JA, et al. Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response. Translational Psychiatry. 11: 439. PMID 34420030 DOI: 10.1038/s41398-021-01564-8 |
0.346 |
|
| 2021 |
Jones BDM, Levitan RD, Wang W, Uher R, Rotzinger S, Foster JA, Kennedy SH, Farzan F, Quilty LC, Kloiber S. Metabolic variables associated with response to cognitive behavioural therapy for depression in females: A Canadian biomarker integration network for depression (CAN-BIND) study. Journal of Psychiatric Research. 142: 321-327. PMID 34419752 DOI: 10.1016/j.jpsychires.2021.07.031 |
0.357 |
|
| 2021 |
van der Wijk G, Harris JK, Hassel S, Davis AD, Zamyadi M, Arnott SR, Milev R, Lam RW, Frey BN, Hall GB, Müller DJ, Rotzinger S, Kennedy SH, Strother SC, MacQueen GM, et al. Baseline Functional Connectivity in Resting State Networks Associated with Depression and Remission Status after 16 Weeks of Pharmacotherapy: A CAN-BIND Report. Cerebral Cortex (New York, N.Y. : 1991). PMID 34416758 DOI: 10.1093/cercor/bhab286 |
0.348 |
|
| 2021 |
Caspani G, Turecki G, Lam RW, Milev RV, Frey BN, MacQueen GM, Müller DJ, Rotzinger S, Kennedy SH, Foster JA, Swann JR. Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report. Communications Biology. 4: 903. PMID 34294869 DOI: 10.1038/s42003-021-02421-6 |
0.365 |
|
| 2021 |
Suh JS, Fiori LM, Ali M, Harkness KL, Ramonas M, Minuzzi L, Hassel S, Strother SC, Zamyadi M, Arnott SR, Farzan F, Foster JA, Lam RW, MacQueen GM, Milev R, ... ... Rotzinger S, et al. Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report. Psychoneuroendocrinology. 132: 105348. PMID 34229186 DOI: 10.1016/j.psyneuen.2021.105348 |
0.334 |
|
| 2021 |
Nunez JJ, Nguyen TT, Zhou Y, Cao B, Ng RT, Chen J, Frey BN, Milev R, Müller DJ, Rotzinger S, Soares CN, Uher R, Kennedy SH, Lam RW. Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1. Plos One. 16: e0253023. PMID 34181661 DOI: 10.1371/journal.pone.0253023 |
0.361 |
|
| 2021 |
Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, McInerney S, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. Cns Drugs. 35: 439-450. PMID 33860922 DOI: 10.1007/s40263-021-00803-2 |
0.347 |
|
| 2021 |
Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW. Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report. Pharmacopsychiatry. PMID 33652477 DOI: 10.1055/a-1385-0263 |
0.334 |
|
| 2020 |
McInerney SJ, Chakrabarty T, Maciukiewicz M, Frey BN, MacQueen GM, Milev RV, Ravindran AV, Rotzinger S, Kennedy SH, Lam RW. Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720974823. PMID 33353384 DOI: 10.1177/0706743720974823 |
0.319 |
|
| 2020 |
Ge R, Hassel S, Arnott SR, Davis AD, Harris JK, Zamyadi M, Milev R, Frey BN, Strother SC, Müller DJ, Rotzinger S, MacQueen GM, Kennedy SH, Lam RW, Vila-Rodriguez F. Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study report. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110194. PMID 33296696 DOI: 10.1016/j.pnpbp.2020.110194 |
0.316 |
|
| 2020 |
Uher R, Frey BN, Quilty LC, Rotzinger S, Blier P, Foster JA, Müller DJ, Ravindran AV, Soares CN, Turecki G, Parikh SV, Milev R, MacQueen G, Lam RW, Kennedy SH, et al. Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 81. PMID 32558407 DOI: 10.4088/Jcp.20M13229 |
0.424 |
|
| 2020 |
Phillips JL, Jaworska N, Kamler E, Bhat V, Blier J, Foster JA, Hassel S, Ho K, McMurray L, Milev R, Moazamigoudarzi Z, Placenza FM, Richard-Devantoy S, Rotzinger S, Turecki G, et al. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. Bmc Psychiatry. 20: 268. PMID 32487236 DOI: 10.1186/S12888-020-02672-3 |
0.464 |
|
| 2020 |
Dunlop K, Rizvi SJ, Kennedy SH, Hassel S, Strother SC, Harris JK, Zamyadi M, Arnott SR, Davis AD, Mansouri F, Schulze L, Ceniti AK, Lam RW, Milev R, Rotzinger S, et al. Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32349119 DOI: 10.1038/S41386-020-0688-X |
0.457 |
|
| 2020 |
Belzeaux R, Gorgievski V, Fiori LM, Lopez JP, Grenier J, Lin R, Nagy C, Ibrahim EC, Gascon E, Courtet P, Richard-Devantoy S, Berlim M, Chachamovich E, Théroux JF, Dumas S, ... ... Rotzinger S, et al. GPR56/ADGRG1 is associated with response to antidepressant treatment. Nature Communications. 11: 1635. PMID 32242018 DOI: 10.1038/S41467-020-15423-5 |
0.396 |
|
| 2020 |
Zhdanov A, Atluri S, Wong W, Vaghei Y, Daskalakis ZJ, Blumberger DM, Frey BN, Giacobbe P, Lam RW, Milev R, Mueller DJ, Turecki G, Parikh SV, Rotzinger S, Soares CN, et al. Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression. Jama Network Open. 3: e1918377. PMID 31899530 DOI: 10.1001/jamanetworkopen.2019.18377 |
0.352 |
|
| 2020 |
Dunlop K, Rizvi S, Hassel S, Strother SC, Lam RW, Milev R, Rotzinger S, Frey BN, Parikh S, Soares C, Uher R, Turecki G, MacQueen G, Kennedy SH, Liston C. Pre-Treatment Resting-State Functional Connectivity Related to Anhedonia and Anxiety are Associated With Antidepressant Response to Escitalopram and Adjunct Aripiprazole Biological Psychiatry. 87: S431. DOI: 10.1016/J.Biopsych.2020.02.1098 |
0.362 |
|
| 2019 |
Hassel S, Sharma GB, Alders GL, Davis AD, Arnott SR, Frey BN, Hall GB, Harris JK, Lam RW, Milev R, Müller DJ, Rotzinger S, Zamyadi M, Kennedy SH, Strother SC, et al. Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants. Human Brain Mapping. PMID 31794150 DOI: 10.1002/Hbm.24883 |
0.309 |
|
| 2019 |
Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Downar J, Parikh SV, Soares CN, Addington JM, ... ... Rotzinger S, et al. Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31610545 DOI: 10.1038/S41386-019-0542-1 |
0.452 |
|
| 2019 |
Ju C, Fiori LM, Belzeaux R, Theroux JF, Chen GG, Aouabed Z, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, ... ... Rotzinger S, et al. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. Translational Psychiatry. 9: 254. PMID 31594917 DOI: 10.1038/S41398-019-0589-0 |
0.388 |
|
| 2019 |
Chakrabarty T, Harkness KL, McInerney SJ, Quilty LC, Milev RV, Kennedy SH, Frey BN, MacQueen GM, Müller DJ, Rotzinger S, Uher R, Lam RW. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 1-12. PMID 31583989 DOI: 10.1017/S003329171900268X |
0.36 |
|
| 2019 |
Davis AD, Hassel S, Arnott SR, Harris J, Lam RW, Milev R, Rotzinger S, Zamyadi M, Frey BN, Minuzzi L, Strother SC, MacQueen GM, Kennedy SH, Hall GB. White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31471185 DOI: 10.1016/J.Bpsc.2019.05.016 |
0.387 |
|
| 2019 |
Braun Janzen T, Al Shirawi MI, Rotzinger S, Kennedy SH, Bartel L. A Pilot Study Investigating the Effect of Music-Based Intervention on Depression and Anhedonia. Frontiers in Psychology. 10: 1038. PMID 31133945 DOI: 10.3389/Fpsyg.2019.01038 |
0.429 |
|
| 2019 |
Belzeaux R, Fiori LM, Lopez JP, Boucekine M, Boyer L, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, Parikh SV, ... Rotzinger S, et al. Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment. The Journal of Clinical Psychiatry. 80. PMID 31087825 DOI: 10.4088/Jcp.18M12556 |
0.305 |
|
| 2019 |
Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Giacobbe P, Hall GB, Harkness KL, Hassel S, Ismail Z, et al. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 80. PMID 30840787 DOI: 10.4088/Jcp.18M12202 |
0.462 |
|
| 2019 |
MacQueen GM, Hassel S, Arnott SR, Jean A, Bowie CR, Bray SL, Davis AD, Downar J, Foster JA, Frey BN, Goldstein BI, Hall GB, Harkness KL, Harris J, Lam RW, ... ... Rotzinger S, et al. The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols Journal of Psychiatry & Neuroscience : Jpn. 44: 1-14. PMID 30840428 DOI: 10.1503/Jpn.180036 |
0.408 |
|
| 2019 |
Islam F, Marshe V, Maciukiewicz M, Lam R, MacQueen G, Frey B, Milev R, Parikh S, Soares C, Uher R, Turecki G, Rotzinger S, Foster JA, Kennedy S, Mueller D. M31 Impact Of Cyp2C19 And Cyp2D6 Gene Variants On Plasma Levels And Treatment Response In Patients Receiving Escitalopram And Aripiprazole For Major Depression: Results From The Can-Bind-1 Cohort European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.08.131 |
0.409 |
|
| 2019 |
Maciukiewicz M, Marshe V, Hauschild A, Foster JA, Rotzinger S, Kennedy JL, Kennedy SH, Müller DJ, Geraci J. GWAS-BASED MACHINE LEARNING APPROACH TO PREDICT DULOXETINE RESPONSE AND REMISSION IN MAJOR DEPRESSIVE DISORDER European Neuropsychopharmacology. 29: S843. DOI: 10.1016/J.Euroneuro.2017.08.110 |
0.414 |
|
| 2019 |
Islam F, Marshe V, Maciukiewicz M, Yoshida K, Lam RW, MacQueen G, Frey BN, Milev R, Parikh S, Soares C, Uher R, Turecki G, Rotzinger S, Foster J, Kennedy SH, et al. S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.875 |
0.407 |
|
| 2019 |
Desjardins C, Nogovitsyn N, Souza R, Hassel S, Arnott S, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Bray S, Lebel C, Addington J, Milev R, Harkness K, ... ... Rotzinger S, et al. F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.650 |
0.393 |
|
| 2019 |
Suh JS, Minuzzi L, Raamana P, Strother SC, MacQueen GM, Hassel S, Alders G, Arnott S, Davis AD, Harris JK, Sharma GB, Zamyadi M, Blier P, Downar J, Farzan F, ... ... Rotzinger S, et al. F107. Cortical Thickness Features Differentiate 16-Week Antidepressant Response Profiles in Major Depressive Disorder Biological Psychiatry. 85: S254. DOI: 10.1016/J.Biopsych.2019.03.644 |
0.409 |
|
| 2018 |
Maciukiewicz M, Marshe VS, Hauschild AC, Foster JA, Rotzinger S, Kennedy JL, Kennedy SH, Müller DJ, Geraci J. GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. Journal of Psychiatric Research. 99: 62-68. PMID 29407288 DOI: 10.1016/J.Jpsychires.2017.12.009 |
0.392 |
|
| 2017 |
Baskaran A, Farzan F, Milev R, Brenner CA, Alturi S, Pat McAndrews M, Blier P, Evans K, Foster JA, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Müller DJ, ... ... Rotzinger S, et al. The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study. Journal of Affective Disorders. 227: 542-549. PMID 29169123 DOI: 10.1016/J.Jad.2017.10.028 |
0.38 |
|
| 2017 |
Farzan F, Atluri S, Frehlich M, Dhami P, Kleffner K, Price R, Lam RW, Frey BN, Milev R, Ravindran A, McAndrews MP, Wong W, Blumberger D, Daskalakis ZJ, Vila-Rodriguez F, ... ... Rotzinger S, et al. Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression. Scientific Reports. 7: 7473. PMID 28785082 DOI: 10.1038/S41598-017-07613-X |
0.316 |
|
| 2017 |
Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Kennedy JL, Rotzinger S, Foster JA, Kennedy SH, Müller DJ. Genome-wide association studies of placebo and duloxetine response in major depressive disorder. The Pharmacogenomics Journal. PMID 28696415 DOI: 10.1038/Tpj.2017.29 |
0.399 |
|
| 2017 |
Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C, Han MH, Foster J, Frey BN, Soares CN, Müller DJ, ... ... Rotzinger S, et al. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nature Communications. 8: 15497. PMID 28530238 DOI: 10.1038/Ncomms15497 |
0.351 |
|
| 2017 |
Fiori LM, Lopez JP, Richard-Devantoy S, Berlim M, Chachamovich E, Jollant F, Foster J, Rotzinger S, Kennedy S, Turecki G. Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response. The International Journal of Neuropsychopharmacology. PMID 28520926 DOI: 10.1093/Ijnp/Pyx034 |
0.382 |
|
| 2017 |
Hassel S, Davis A, Hall G, Foster J, Harkness K, Harris J, Zamyadi M, Arnott S, Alders G, Rotzinger S, Strother S, Kennedy S, MacQueen G. 754. Inflammatory Markers as Mediators of the Association between Early Life Adversity and Hippocampal Volume in Adult Patients with depression: Findings from Phase 1 of the CAN-BIND Study Biological Psychiatry. 81: S306. DOI: 10.1016/J.Biopsych.2017.02.821 |
0.371 |
|
| 2017 |
Harkness K, Wynne-Edwards K, Foster J, Rotzinger S, Kennedy S. 751. The Role of Childhood Maltreatment in Depression: Overview of the Literature and Insights from the CAN-BIND Program Biological Psychiatry. 81: S304-S305. DOI: 10.1016/J.Biopsych.2017.02.818 |
0.378 |
|
| 2016 |
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Geraci J, Giacobbe P, et al. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. Bmc Psychiatry. 16: 105. PMID 27084692 DOI: 10.1186/S12888-016-0785-X |
0.467 |
|
| 2015 |
Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Rotzinger S, Foster JA, Kennedy JL, Kennedy SH, Müller DJ. Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder. Pharmacogenomics. PMID 26556688 DOI: 10.2217/Pgs.15.136 |
0.365 |
|
| 2014 |
Rizvi SJ, Grima E, Tan M, Rotzinger S, Lin P, Mcintyre RS, Kennedy SH. Treatment-resistant depression in primary care across Canada. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 59: 349-57. PMID 25007419 DOI: 10.1177/070674371405900702 |
0.405 |
|
| 2012 |
Kennedy SH, Downar J, Evans KR, Feilotter H, Lam RW, MacQueen GM, Milev R, Parikh SV, Rotzinger S, Soares C. The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Current Pharmaceutical Design. 18: 5976-89. PMID 22681173 DOI: 10.2174/138161212803523635 |
0.474 |
|
| 2011 |
Rizvi SJ, Donovan M, Giacobbe P, Placenza F, Rotzinger S, Kennedy SH. Neurostimulation therapies for treatment resistant depression: A focus on vagus nerve stimulation and deep brain stimulation International Review of Psychiatry. 23: 424-436. PMID 22200132 DOI: 10.3109/09540261.2011.630993 |
0.402 |
|
| 2010 |
Rotzinger S, Lovejoy DA, Tan LA. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides. 31: 736-56. PMID 20026211 DOI: 10.1016/J.Peptides.2009.12.015 |
0.413 |
|
| 2009 |
Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S. Teneurin C-terminal associated peptide (TCAP)-1 attenuates corticotropin-releasing factor (CRF)-induced c-Fos expression in the limbic system and modulates anxiety behavior in male Wistar rats. Behavioural Brain Research. 201: 198-206. PMID 19428634 DOI: 10.1016/J.Bbr.2009.02.013 |
0.308 |
|
| 2008 |
Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S. Repeated intracerebral teneurin C-terminal associated peptide (TCAP)-1 injections produce enduring changes in behavioral responses to corticotropin-releasing factor (CRF) in rat models of anxiety. Behavioural Brain Research. 188: 195-200. PMID 18082275 DOI: 10.1016/J.Bbr.2007.10.032 |
0.303 |
|
| 2007 |
Al Chawaf A, Xu K, Tan L, Vaccarino FJ, Lovejoy DA, Rotzinger S. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1). Peptides. 28: 1406-15. PMID 17644218 DOI: 10.1016/J.Peptides.2007.05.014 |
0.317 |
|
| Show low-probability matches. |